T. Rowe Price Associates’s Sutro Biopharma STRO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-36,893
| Closed | -$25K | – | 3143 |
|
|
2025
Q1 | $25K | Buy |
36,893
+6,694
| +22% | +$4.54K | ﹤0.01% | 2993 |
|
|
2024
Q4 | $56K | Buy |
30,199
+3,944
| +15% | +$7.31K | ﹤0.01% | 2915 |
|
|
2024
Q3 | $91K | Hold |
26,255
| – | – | ﹤0.01% | 2836 |
|
|
2024
Q2 | $77K | Buy |
26,255
+8,228
| +46% | +$24.1K | ﹤0.01% | 2788 |
|
|
2024
Q1 | $102K | Buy |
18,027
+3,578
| +25% | +$20.2K | ﹤0.01% | 2780 |
|
|
2023
Q4 | $62K | Buy |
14,449
+1,335
| +10% | +$5.73K | ﹤0.01% | 2775 |
|
|
2023
Q3 | $46K | Buy |
13,114
+1,566
| +14% | +$5.49K | ﹤0.01% | 2783 |
|
|
2023
Q2 | $54K | Buy |
+11,548
| New | +$54K | ﹤0.01% | 2788 |
|
|
2021
Q2 | – | Sell |
-21,399
| Closed | -$487K | – | 2944 |
|
|
2021
Q1 | $487K | Buy |
21,399
+431
| +2% | +$9.81K | ﹤0.01% | 2378 |
|
|
2020
Q4 | $455K | Buy |
+20,968
| New | +$455K | ﹤0.01% | 2279 |
|